Corixa (NASDAQ: CRXA) was a biotechnology/pharmaceutical company based in Seattle, Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operates a laboratory and production facility in Hamilton, Montana. NASDAQ in Times Square, New York City. ... The structure of insulin Biotechnology is technology based on biology, especially when used in agriculture, food science, and medicine. ... Pharmacology (in Greek: pharmacon is drug, and logos is science) is the study of how chemical substances interfere with living systems. ... Nickname: The Emerald City Location of Seattle in King County and Washington Coordinates: Country United States State Washington County King Incorporated December 2, 1869 Mayor Greg Nickels (D) Area    - City 369. ... Immunotherapy is a form of medical treatment based upon the concept of modulating the immune system to achieve a therapeutic goal. ... Autoimmune diseases arise from an overactive immune response of the body against substances and tissues normally present in the body. ... In medicine, infectious disease or communicable disease is disease caused by a biological agent such as by a virus, bacterium or parasite. ... Cancer is a class of diseases or disorders characterized by uncontrolled division of cells and the ability of these cells to invade other tissues, either by direct growth into adjacent tissue through invasion or by implantation into distant sites by metastasis. ... 1994 (MCMXCIV) was a common year starting on Saturday of the Gregorian calendar, and was designated as the International Year of the Family and the International Year of the Sport and the Olympic Ideal by United Nations. ... Hamilton is a city in Ravalli County, Montana, United States. ...

The name Corixa comes from the fly lure. Blue Winged Olive, a classic dry fly for trout. ...

On 12th July 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa. GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a British based pharmaceutical, biologicals, and healthcare company. ... MPL may refer to: Mozilla Public License MPL Communications This is a disambiguation page — a navigational aid which lists other pages that might otherwise share the same title. ... In medicine, adjuvants are agents which modify the effect of other agents while having few if any direct effects when given by themselves. ... A vaccine is an antigenic preparation used to establish immunity to a disease. ...

On 31 March 2006, Corixa's doors closed after over 11 years in business.

External links

• Corixa website